LinkedIn (LNKD) estimates, target were boosted at Morgan Stanley. Shares are now seen reaching $210, according to Morgan Stanley. Estimates also upped, given higher marketing solutions growth. Overweight rating.
Nokia (NOK) estimates, target were cut at Canaccord. Shares are now seen reaching $3.50, according to Canaccord Genuity. Estimates also reduced, as the company is likely losing market share to Samsung. Hold rating.
Monsanto (MON) price target and earnings estimates through 2014 were increased at Citi. Soybeans should drive growth starting in 2014 and the accelerated buyback is also a catalyst, said Citigroup. Price target goes to $122.
Monsanto estimates, target raised at Piper as the company is carrying a lot of momentum into the planting season. Overweight rating.New York Community Bancorp (NYCB) estimates were reduced at Citi through 2014 to reflect a soft quarter. Lower pre-payments and margins are expected and the anticipated accretive merger is unlikely to happen, said Citigroup. Thermo Fisher (TMO) price target increased to $87 at UBS. Industry commentary has been positive, top line momentum remains intact and productivity and capital deployment will benefit the company, said UBS. Valent (VRX) price target and estimates were reduced given the introduction of a generic version of Zovirax Ointment, said UBS. Price target goes to $81. >To submit a news tip, email: firstname.lastname@example.org. Follow TheStreet on Twitter and become a fan on Facebook.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV